Cancer’s Unique
Mutational Fingerprint

Every cancer is unique. We profile each patient’s mutational fingerprint to define the right treatment strategy.

READ MORE

Cancer’s Weakness:
Hiding in Plain Sight

Neoantigens are ideal, untapped targets against cancer.

READ MORE

Advancing in the Clinic

We are leaders in the clinical development of neoantigen-based therapies.

READ MORE